Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.

Fiche publication


Date publication

août 2019

Journal

World journal of gastroenterology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BEN ABDELGHANI Meher, Pr BOUCHE Olivier


Tous les auteurs :
Bouché O, Ben Abdelghani M, Labourey JL, Triby S, Bensadoun RJ, Jouary T, Des Guetz G

Résumé

Anti-epidermal growth factor receptor therapy is associated with skin adverse events not previously reported with conventional chemotherapy. Prophylactic actions are recommended, but routine clinical management of these toxicities and their impact on quality of life remain unknown.

Mots clés

Epidermal growth factor receptor inhibitors, Metastatic colorectal cancer, Panitumumab, Quality of life, Skin toxicity

Référence

World J. Gastroenterol.. 2019 Aug 7;25(29):4007-4018